Home › Funds › Aaron Wealth Advisors LLC › MBX
Aaron Wealth Advisors LLC position in MBX
MBX BIOSCIENCES INC COM · Health Care
Aaron Wealth Advisors LLC reported holding 1,175,771 shares of MBX (MBX BIOSCIENCES INC COM) in its Q3 2026 13F filing — a position valued at US$68.9M, representing 3.37% of its reported portfolio and ranking #7 among its reported holdings. Aaron Wealth Advisors LLC has disclosed MBX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Aaron Wealth Advisors LLC's MBX position evolved
Aaron Wealth Advisors LLC first disclosed a stake in MBX in Q1 2025 at 50,000 shares (US$369K). The position peaked in Q3 2026 at 1,175,771 shares, worth US$68.9M. Across 7 filings, Aaron Wealth Advisors LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 1,175,771 shares valued at US$68.9M — an increase of 7,972 shares quarter over quarter.. Notable position changes include a 40% increase in Q4 2025 (shares fell 5% over the following quarter), a 1569% increase in Q1 2026 (shares rose 85% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 50.00K | $369.00K | New |
| Q2 2025 | 50.00K | $570.50K | Hold |
| Q3 2025 | 50.00K | $875.00K | Hold |
| Q4 2025 | 70.00K | $2.21M | Add |
| Q1 2026 | 1.17M | $34.87M | Add |
| Q2 2026 | 1.17M | $64.46M | Hold |
| Q3 2026 | 1.18M | $68.92M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MBX and 13F data
MBX (MBX BIOSCIENCES INC COM) is a Health Care company. 73 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$367.2M), NEA Management Company, LLC (US$199.5M), ORBIMED ADVISORS LLC (US$189.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MBX
- Frazier Life Sciences Management, L.P. 6.65M sh · $367.19M · Q2 2026
- NEA Management Company, LLC 3.61M sh · $199.52M · Q2 2026
- ORBIMED ADVISORS LLC 3.43M sh · $189.27M · Q2 2026
- Paradigm Biocapital Advisors LP 2.51M sh · $138.44M · Q2 2026
- NVP Associates, LLC 2.14M sh · $117.93M · Q2 2026
- Deep Track Capital, LP 1.73M sh · $95.64M · Q2 2026
- Kynam Capital Management, LP 934.80K sh · $51.60M · Q2 2026
- Parkman Healthcare Partners LLC 800.17K sh · $44.17M · Q2 2026
- BRAIDWELL LP 710.88K sh · $39.24M · Q2 2026
- TCG Crossover Management, LLC 650.00K sh · $35.88M · Q2 2026
- Cormorant Asset Management, LP 550.00K sh · $30.36M · Q2 2026
- Soleus Capital Management, L.P. 515.28K sh · $28.44M · Q2 2026
More on Aaron Wealth Advisors LLC
FAQ
How long has Aaron Wealth Advisors LLC held MBX?
Aaron Wealth Advisors LLC has disclosed MBX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Aaron Wealth Advisors LLC's current position in MBX?
As of Q3 2026, Aaron Wealth Advisors LLC holds 1.18M shares of MBX (MBX BIOSCIENCES INC COM), valued at $68.92M, representing 3.37% of its reported portfolio and ranking #7.
Has Aaron Wealth Advisors LLC been buying or selling MBX?
In the latest 13F filing (Q3 2026), Aaron Wealth Advisors LLC increased its position in MBX. The position peaked in Q3 2026 at 1.18M shares.
Which other funds hold MBX?
Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., NEA Management Company, LLC, ORBIMED ADVISORS LLC, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.